V

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

General Ledger Accounting Co-op

Financial AccountingPosted on Nov 10
Internship · Winter 2027Boston, MA, USA

About the Job

Requirements

  • Currently enrolled in a college or university with at least two years completed toward a bachelor's degree; recent graduates are eligible if they plan to return to graduate school.
  • Maintain a minimum cumulative GPA of 3.2.
  • Demonstrate strong attention to detail and organizational skills.
  • Have written and verbal communication abilities.
  • Be able to manage multiple tasks in a fast-paced environment and prioritize effectively.
  • Be capable of working independently and collaboratively within a team.
  • Be proficient in Microsoft Office Suite, including Excel, Word, and PowerPoint.
  • Have previous internship or co-op experience in accounting.
  • Have legal authorization to work in the United States now and in the future.
  • Be enrolled in an advanced degree program if graduating before June 2027.
  • Be available to work full-time, 40 hours per week from January through June 2027.

Responsibilities

  • Support cash management and other general accounting activities during the monthly general ledger close.
  • Assist with post-close governance analysis to understand key close activities, dependencies, and opportunities to improve close efficiency.
  • Support the general ledger team on projects and initiatives, which may include project testing, system implementations, integration activities, and process improvement efforts.
  • Support project coordination, action-item tracking, documentation, and testing as project needs require.

About the Company

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1989

Recently Posted Jobs

Explore more opportunities at Vertex Pharmaceuticals

See more jobs